PPAR-γ: Adipogenic regulator and thiazolidinedione receptor

Diabetes

Volumn 47, Issue 4, 1998, Pages 507-514

  Spiegelman, Bruce M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TROGLITAZONE;

ADIPOCYTE; CELL DIFFERENTIATION; DRUG RECEPTOR BINDING; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET ORGAN;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; TRANSCRIPTION FACTORS;

EID: 0031898610     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.4.507     Document Type: Review

References (52)

1. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389, 1996
2. Graves RA, Tontonoz P, Spiegelman BM: Analysis of a tissue-specific enhancer. ARF6 regulates adipogenic gene expression. Mol Cell Biol 12:1202-1208, 1992
3. Tontonoz P, Hu E, Graves RA, Budavari AB, Spiegelman BM: mPPAR-γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
4. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W: Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879-887, 1992
5. Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK: Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem 268:26817-26820, 1993
6. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of marine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359, 1994
7. Tontonoz P, Graves RA, Budavari AB, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM: Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR-γ2 and RXRα. Nucleic Acids Res 22:5628-5634, 1994
8. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS: Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
9. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM: PPAR-γ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351-357, 1995
10. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR-γ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
11. Brun RP, Kim JB, Hu E, Spiegelman BM: Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr Opin Lipidol 8:212-218, 1997
12. MacDougald OA, Lane MD: Transcriptional regulation of gene expression during adipocyte differentiation. Ann Rev Biochem 64:345-373, 1995
13. Hu E, Tontonoz P, Spiegelman BM: Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR-γ and C/EBPα. Proc Natl Acad Sci USA 92:9856-9860, 1995
14. Tontonoz P, Kim JB, Graves RA, Spiegelman BM: ADD1: a novel helix-loop-helix protein associated with adipocyte determination and differentiation. Mol Cell Biol 13:4753-4759, 1993
15. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS: SREBP-1, a basic helix-loop-helix, loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187-197, 1993
16. Kim JB, Spiegelman BM: ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10:1096-1107, 1996
17. Wu Z, Xie Y, Bucher NLR, Farmer SR: Conditional ectopic expression of C/EBP-β in NIH-3T3 cells induces PPAR-γ and stimulates adipogenesis. Genes Dev 9:2350-2356, 1995
18. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two PPAR gamma isoforms. Proc Natl Acad Sci USA 92:7921-7925, 1995
19. Harris PK, Kletzien RF: Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol Pharmacol 45:439-445, 1994
20. Lehmann JM, Morre LB, Smith-Oliver TA, Wilkison WO, Wilson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ.J Biol Chem 270:12953-12956, 1995
21. 12,14-Prostagalandin J2 is a ligand for the adipocyte determination factor PPAR-γ. Cell 83:803-812, 1995
22. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668, 1996
23. Mukherjee R, Davies PJ, Crombi DL, Bischoff ED, Cesario RM, Jow L, Boehm MF, Modon CE, Nadzan AM, Paterniti JR Jr. Heyman RA: Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386:407-410, 1997
24. Hallakou S, Doare L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferre P: Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46:1393-1399, 1997
25. Henry RR: Thiazolidinediones. Endocrinol Metab Clin North Am 26:9553-9573, 1997
26. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC: Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50:1087-1094, 1996
27. Food and Drug Administration: FDA Talk Paper. Washington, DC, U.S. Department of Health and Human Services, December 1, 1997
28. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819, 1995
29. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-4323, 1997
30. Burant CF, Sreenan S, Hirano K, Tai T-AC, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA: Troglitazone action is independent of adipose tissue. J Clin Invest 100:2900-2908, 1997
31. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
32. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
33. Tai TAC, Jennermann C, Brown KK, Oliver BB, MacGinnitie MA, Wilkison WO, Brown HR, Lehmann JM, Kliewer SA, Morris DC, Graves RA: Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J Biol Chem 271:29909-29914, 1996
34. Foellmi-Adams LA, Wyse BM, Herron D, Nedergaard J, Kletzien RF: Induction of uncoupling protein in brown adipose tissue: synergy between norepinephrine and pioglitazone, an insulin-sensitizing agent. Biochem Pharm 52:693-701, 1996
35. Hotamisligil G, Shargill N, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
36. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614, 1997
37. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor P: Effects of an engineered human anti-TNF-α antibody (CD571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
38. Hofman C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
39. Peraldi P, Xu M, Spiegelman BM: Thiazolidinediones block TNF-α-induced inhibition of insulin signaling. J Clin Invest 100:1863-1869, 1997
40. Mues PDG, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM: TNF-αinduced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46:1678-1683, 1997
41. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796, 1996
42. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma, J Clin Invest 98:1004-1009, 1996
43. Muller G, Ertl J, Geri M, Preibisch G: Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 272:10585-10593, 1997
44. Lefebvre AM, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart JC, Fievet C, Auwerx J, Staels B: Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vase Biol 17:1756-1764, 1997
45. Hotamisligil GS, Distel RJ, Johnson RS, Papaioannou V, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in the fatty acid binding protein aP2. Science, 274:1377-1379, 1996
46. Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA: Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes: association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 44:1087-1092, 1995
47. Wu Z, Xie Y, Bucher NLR, Farmer SR PPAR(gamma) induces the insulin-dependent glucose transporter, GLLT4, in the absence of C/EBP(alpha) during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 101:22-32, 1998
48. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-γ. Science 274:2100-2103, 1996
49. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK: Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132, 1997
50. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW: Role of co-activators and co-repressors in the mechanism of steroid thyroid receptor action. Recent Prog Horm Res 52:141-164, 1997
51. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684, 1997
52. Pazin MJ, Kadonaga JT: What's up and down with histone deacetylation and transcription? Cell 89:325-328, 1997